United States · 
Who invested in Aptimmune Biologics?
Aptimmune Biologics's investors include Arsenal Capital Partners and Fox Ventures.
United States · Series A startup
Who invested in Aptimmune Biologics
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$2.8Mraised across 1 round since 2015, from 1 source
- Latest round
- Series A, $2.8MJul 2015
- Investors
- 2
The rounds
- Jul 2015Series A$2.8M
From a historical funding recordSEC filing: $1.1M sold, first sale Jun 2015
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Aptimmune Biologics
How much has Aptimmune Biologics raised?
Aptimmune Biologics has raised $2.8M across 1 round since 2015.
When did Aptimmune Biologics last raise?
Aptimmune Biologics's most recent round was a Series A of $2.8M in Jul 2015.
What was Aptimmune Biologics's biggest round?
Its most recent round, $2.8M in Jul 2015, is also its largest on record.
Who backed Aptimmune Biologics first?
Aptimmune Biologics's first round on record, in Jul 2015, was backed by Arsenal Capital Partners and Fox Ventures.
What stage is Aptimmune Biologics at?
Aptimmune Biologics's latest named round is a Series A, in Jul 2015.
Where is Aptimmune Biologics based?
Aptimmune Biologics is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.